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Antibacterial and antifungal agents are widely used in the management of infectious disease but most of them have 
developed resistance to micro-organism. To overcome this problem and to lower the side effects, many approaches 
can be utilized.  Benzophenone derivatives are reported to have the broad spectrum of biological activities. In the 
present study we have screened benzophenone derivatives 5a-k against six bacterial species viz gram positive 
(Bacillus subtilis and Staphylococcus aureus) and gram negative (Pseudomonas aeruginosa, Salmonella typhi, 
Proteus vulgaris, Shigella flexneri) bacteria. Also compounds 5a-k were tested with six fungal species viz (Candida 
albicans, Aspergillus niger, Fusarium solani, Aspergillus flavus, Botrytis cinerea, Candida krusei). The obtained 
results showed that the synthesized compounds 5a-k exhibited moderate to good activities against all the tested 
strains. Compounds 5a, 5c, 5d, 5f and 5g have shown good antibacterial and antifungal activities against selected 
strains. 
 





Infections diseases represent a critical issue for health and the major cause of morbidity and mortality worldwide. 
Despite significant progress in human medicine, infections diseases caused by microorganisms are still a serious 
threat to public health. The impact is even greater in developing countries due to unavailability of medicine in all the 
locations, the practice of self-medication and the emergence of microorganism drug resistance1. The development of 
resistance to current antibacterial therapy continues to drive the search for more effective agents. In addition, 
primary and opportunistic fungal infections continue to increase the number of immune compromised patients, those 
suffering from such as AIDS or cancer or who have undergone organ transplantation.  
 
 In recent years, the incidence of fungal and bacterial infections has increased dramatically. The widespread use of 
antibacterial and antifungal drugs resulted in resistance to drug therapy against bacterial and fungal infections which 
led to serious health hazards. The resistance of wide spectrum antibacterial and antifungal agents has initiated 
discovery and modification of the new antibacterial and antifungal drugs.  
 
Benzophenones are a class of compounds obtained from natural products2 or by synthetic methods3. The structural 
features of benzophenones have been of tremendous interest in medicinal, chemical and industrial fields. Many 




benzophenone derivatives are reported to have the broad spectrum of biological activities, such as CNS depressant4, 
antimalarial5, antimitotic6, antiprotozoal7, antiulcer8, antibacterial9, antioxidant, spermicidal10, antitumor11, and anti-
inflammatory12 activities. The aim of this study was to investigate antibacterial and antifungal effects of 
benzophenone derivatives against a panel of bacteria and fungi.  
 
MATERIALS AND METHODS 
 
Chemicals were purchased from Aldrich Chemical Co. TLC was performed on aluminium-backed silica plated with 
visualization by UV-light. Melting points were determined on a Thomas Hoover capillary melting point apparatus 
with a digital thermometer. IR spectra were recorded in Nujol on FT-IR Shimadzu 8300 spectrometer and 1H NMR 
spectra were recorded on a Bruker (300 MHz) spectrometer in CDCl3. Chemical shifts were recorded in parts per 
million downfield from tetramethylsilane. Mass spectra were obtained with a VG70-70H mass spectrometer and 
elemental analysis results are within 0.4% of the calculated value. 
  
Chemistry 
The synthesis of the hitherto reported title compounds 5a-k is as outlined in scheme 1. Hydroxybenzophenones 1a-e 
on reaction with ethyl chloroacetate affords ethyl (2-aroyl-4-methylphenoxy) acetates 2a-e in excellent yield, which 
on alkaline hydrolysis afforded (2-aroyl-4-methylphenoxy)ethanoic acid 3a-e. Compounds 3a-e on condensation 
with substituted aromatic amines 4a-c in presence of boron trifluoride etherate and dry benzene furnished 





The in-vitro antimicrobial activity of all the synthesized compounds 5a-k at different concentrations (20,40,60 and 
80 µg/ml) were studied by agar well diffusion method13-15 against six bacterial species viz gram positive (Bacillus 
subtilis and Staphylococcus aureus) and gram negative (Pseudomonas aeruginosa, Salmonella typhi, Proteus 
vulgaris and Shigella flexneri) bacteria. Also compounds 5a-k were tested with six fungal species viz (Candida 
albicans, Aspergillus niger, Fusarium solani, Aspergillus flavus, Botrytis cinerea and Candida krusei). All the 
organisms were obtained from stock cultures which were maintained on nutrient agar medium and Sabouraud’s 
dextrose agar medium at 40oC, then subcultures in nutrient broth at 37oC, prior to each antimicrobial test. The 
antibacterial activities of all the synthesized compounds were compared with standard drug streptomycin and 




antifungal activity with fluconazole. The zone of inhibitions was determined by measuring scale as per standard 
procedure14. The experiment was repeated thrice, the mean values were tabulated. 
 
RESULTS AND DISCUSSION 
 
Antimicrobial and antifungal activity 
The antibacterial activity of the synthesized compounds 5a-k was assessed in comparison with streptomycin and 
antifungal activity with fluconazole as standard drugs against the Gram-positive, Gram-negative bacteria and fungal 
pathogens using agar well diffusion method and the results are summarized in (Table 1, 2). The obtained results 
showed that the synthesized compounds 5a–k exhibited moderate to good activities against all tested strains. 
Compounds 5a, 5c, 5d, 5f and 5g have shown good antibacterial and antifungal activities while compounds 5b, 5h-k 
exhibit moderate activities against selected organisms at the concentration 80 µg/ml compared to the standards (20 
µg/ml).  
 
Table 1: Antibacterial activity of compounds 5a-k 
 
Zones of Inhibition of bacteria in mm 























































































































































































































































































































































Streptomycin  20 35     23 30 33 29 25 
Control - - - - - - - 
 




Table 2: Antifungal activity of compounds 5a-k 
 
Zones of Inhibition of bacteria in mm 


































































































































































































































































































































Fluconazole 20 29 32 27 33     35 39 
Control - - - - - - - 
 
The investigation on the structure-activity relationship shows that, in general the presence of halo groups at the 
phenyl rings enhanced the antibacterial and antifungal action of the synthesized compounds. 
 
It is worthwhile to note that compound 5a exhibits significant antibacterial and antifungal activities, possibly due to 
the presence of chloro group at the para position of the phenyl rings. Besides compound 5d has less activity than 5a 
may be due to the presence of chloro group at ortho position, also bromo substituted compounds 5c and 5g exhibited 
good activity. Further, the presence of methoxy groups in compound 5e and 5h and butoxy groups in compounds 5i-




In conclusion, a series of eleven compounds were screened in vitro against six bacteria and six fungi. The 
synthesized compounds have a great interest because there have been few reports on the synthesis and antimicrobial 




studies of benzophenone derivatives cited in the literature. In the present study, in vitro antimicrobial activity of 
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